The Galleria Vittorio Emanuele II in Milan hosted Vogue World 2026 this past Tuesday, serving as a high-profile stage for the world's most famous designers.. While the event was intended to celebrate the heritage of Italian craftsmanship, it became a flashpoint for intense discussions regarding artificial intelligence and pharmaceutical industry influence.
The 1,680-hour Valentino gown and the 'Made in Italy' legacy
The event was designed to honor the "Made in Italy" ethos, emphasizing the meticulous human skill required to produce luxury goods. According to the report, supermodel Gigi Hadid set a high bar for the evening, opening the half-hour show in a Valentino haute couture gown that required 1,680 hours of labor to complete.. this focus on artisanal mastery was further highlighted by Jennifer Lopez, who walked the runway in a 1950s-style black lace Dolce & Gabbana cocktail dress.
The runway showcased a massive array of Italy's most storied fashion houses, including Armani, Gucci, Versace, Prada, and Fendi. The audience was equally star-studded, featuring 56-year-old Naomi Campbell in a Matieres Fecales tweed suit and 59-year-old Pamela Anderson in a gold Ferragamo gown. These moments were intended to reinforce Milan's status as the global epicenter of luxury and craftsmanship.
Miuccia Prada and Alessandro Michele's reaction to humanoid robots
The traditional atmosphere of the runway was disrupted when four humanoid robots joined the moels on the catwalk. This integration of technology sparked immediate backlash from some spectators, with one social media viewer noting that the robots appeared to be walking without any clothing. The tension was palpable among the industry's elite;the report notes that Valentino’s creative director Alessandro Michele and Prada’s Miuccia Prada reportedly declined to clap during this specific segment.
The Eli Lilly sponsorship and the Mounjaro controversy
A significant point of contention at Vogue World Milan 2026 was the presence of Eli Lilly, the American pharmaceutical giant, as a primary sponsor. The company is widely recognized for manufacturing Mounjaro, a prominent weight-loss medication. This sponsorship created an awkward juxtaposition within a fashion industry that has historically been criticized for promoting unrealistic and thin body standards.
The presence of a weight-loss drug manufacturer at a premier fashion event highlights a growing tension between the industry's aesthetic traditions and the biological realities of modern health trends. It raises questions about whether fashion is embracing body diversity or simply pivoting to a new form of medicalized beauty.
Who is driving the push for AI in Italian couture?
While the event celebrated human artistry, the inclusion of robots and the comments from Vogue Italia’s head of editorial content, Francesca Ragazzi, suggest a shifting landscape. Ragazzi noted that the event felt "particularly meaningful in the era of artificial intelligence." However, several questions remain regarding the actual role of technology in the creative process.
It remains unclear if the humanoid robots were a one-time spectacle or a signal of a permanent shift toward automated fashion. Furthermore,the report does not clarify if the Eli Lilly sponsorship was a strategic move to align with health-conscious trends or a purely financial decision, leaving the industry to debate the ethics of such a partnership and the true intent behind the technological integration.
Comments 0